Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
|
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
  • [31] Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?
    L. Bartalena
    G. Veronesi
    G. E. Krassas
    W. M. Wiersinga
    C. Marcocci
    M. Marinò
    M. Salvi
    C. Daumerie
    C. Bournaud
    M. Stahl
    L. Sassi
    C. Azzolini
    K. G. Boboridis
    M. P. Mourits
    M. R. Soeters
    L. Baldeschi
    M. Nardi
    N. Currò
    A. Boschi
    M. Bernard
    G. von Arx
    P. Perros
    G. J. Kahaly
    Journal of Endocrinological Investigation, 2017, 40 : 547 - 553
  • [32] Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves' orbitopathy: a meta-analysis
    Feng, Wenwen
    Hu, Yifang
    Zhang, Chengzhou
    Shi, He
    Zhang, Peng
    Yang, Yanli
    Chen, Shiying
    Cui, Weijiang
    Cui, Dai
    BIOENGINEERED, 2022, 13 (06) : 14719 - 14729
  • [33] Low-Dose Rituximab for Active Moderate to Severe Graves' Orbitopathy Resistant to Conventional Treatment
    Du Pasquier-Fediaevsky, Laurence
    Andrei, Stefan
    Berche, Michel
    Leenhardt, Laurence
    Heron, Emmanuel
    Riviere, Sebastien
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (05) : 844 - 850
  • [34] Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?
    Tanda, M. L.
    Piantanida, E.
    Masiello, E.
    Cusini, C.
    Bartalena, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (03) : 351 - 352
  • [35] Clinical and immunological changes in patients with active moderate-to-severe Graves' orbitopathy treated with very low-dose rituximab
    Karasek, David
    Cibickova, Lubica
    Karhanova, Marta
    Kalitova, Jana
    Schovanek, Jan
    Frysak, Zdenek
    ENDOKRYNOLOGIA POLSKA, 2017, 68 (05) : 498 - 504
  • [36] Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves’ orbitopathy?
    M. L. Tanda
    E. Piantanida
    E. Masiello
    C. Cusini
    L. Bartalena
    Journal of Endocrinological Investigation, 2019, 42 : 351 - 352
  • [37] Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves' orbitopathy: an observational study
    Boutzios, Georgios
    Chatzi, Sofia
    Goules, Andreas V.
    Mina, Areti
    Charonis, George C.
    Vlachoyiannopoulos, Panayiotis G.
    Tzioufas, Athanasios G.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Prevalence of Radiological Signs of Dysthyroid Optic Neuropathy in Magnetic Resonance Imaging in Patients with Active, Moderate-to-Severe, and Very Severe Graves Orbitopathy
    Rutkowska-Hinc, Beata
    Maj, Edyta
    Jablonska, Anna
    Milczarek-Banach, Justyna
    Bednarczuk, Tomasz
    Miskiewicz, Piotr
    EUROPEAN THYROID JOURNAL, 2018, 7 (02) : 88 - 94
  • [39] Efficacy of rituximab in treating steroid-resistant Graves' orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China
    Zhang, Ziyin
    Feng, Xiaohui
    Guo, Yaoyao
    Kang, Xiaonan
    Wang, Dan
    Zhang, Jing
    Zeng, Zhixuan
    Yuan, Gang
    HELIYON, 2024, 10 (11)
  • [40] Glucocorticoid-induced adrenal insufficiency after therapy with intravenous methylprednisolone in patients with moderate-to-severe and active Graves' orbitopathy: assessment with a low-dose corticotropin test
    Pelewicz, K.
    Miskiewicz, P.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (08) : 1987 - 1994
12345